Deutsche Bank AG Has $20.36 Million Holdings in Maximus Inc. (MMS)

Deutsche Bank AG raised its stake in Maximus Inc. (NYSE:MMS) by 15.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 284,516 shares of the health services provider’s stock after acquiring an additional 38,960 shares during the period. Deutsche Bank AG owned approximately 0.44% of Maximus worth $20,363,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in MMS. Amundi Pioneer Asset Management Inc. acquired a new position in Maximus in the 4th quarter valued at $163,000. Steward Partners Investment Advisory LLC acquired a new position in Maximus in the 4th quarter valued at $169,000. Capital One National Association acquired a new position in Maximus in the 4th quarter valued at $213,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Maximus by 51.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,581 shares of the health services provider’s stock valued at $256,000 after acquiring an additional 1,214 shares in the last quarter. Finally, Belpointe Asset Management LLC acquired a new position in Maximus in the 3rd quarter valued at $269,000. 96.71% of the stock is owned by hedge funds and other institutional investors.

How to Become a New Pot Stock Millionaire

MMS stock opened at $63.86 on Friday. The company has a current ratio of 2.57, a quick ratio of 2.57 and a debt-to-equity ratio of 0.01. Maximus Inc. has a fifty-two week low of $57.12 and a fifty-two week high of $72.71. The company has a market capitalization of $4,387.58, a price-to-earnings ratio of 19.01, a PEG ratio of 2.24 and a beta of 1.18.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, February 8th. The health services provider reported $0.78 EPS for the quarter, topping analysts’ consensus estimates of $0.77 by $0.01. Maximus had a return on equity of 22.93% and a net margin of 8.99%. The company had revenue of $623.10 million during the quarter, compared to analysts’ expectations of $624.36 million. During the same quarter in the previous year, the firm earned $0.71 EPS. Maximus’s revenue was up 2.6% on a year-over-year basis. research analysts expect that Maximus Inc. will post 3.44 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 28th. Stockholders of record on Thursday, February 15th were issued a dividend of $0.045 per share. The ex-dividend date was Wednesday, February 14th. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.28%. Maximus’s dividend payout ratio (DPR) is currently 5.36%.

In other news, CEO Richard A. Montoni sold 30,000 shares of the business’s stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $67.89, for a total transaction of $2,036,700.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Richard A. Montoni sold 10,000 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $67.42, for a total value of $674,200.00. The disclosure for this sale can be found here. Insiders have sold a total of 44,600 shares of company stock valued at $3,014,830 in the last three months. 3.10% of the stock is owned by insiders.

Several equities analysts have weighed in on MMS shares. Zacks Investment Research raised Maximus from a “hold” rating to a “buy” rating and set a $71.00 price objective for the company in a report on Tuesday, February 13th. Canaccord Genuity reaffirmed a “buy” rating on shares of Maximus in a report on Wednesday, December 27th. Finally, Maxim Group reaffirmed a “hold” rating and issued a $69.00 price objective (up from $66.00) on shares of Maximus in a report on Thursday, February 8th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company. Maximus currently has a consensus rating of “Hold” and a consensus price target of $66.60.

WARNING: This piece was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3295292/deutsche-bank-ag-has-20-36-million-holdings-in-maximus-inc-mms.html.

Maximus Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus Inc. (NYSE:MMS).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

RSP Permian  Given a $69.00 Price Target by Stephens Analysts
RSP Permian Given a $69.00 Price Target by Stephens Analysts
Sandler O’Neill Analysts Give Simmons First National  a $35.00 Price Target
Sandler O’Neill Analysts Give Simmons First National a $35.00 Price Target
Wells Fargo Downgrades Emergent BioSolutions  to Market Perform
Wells Fargo Downgrades Emergent BioSolutions to Market Perform
Targa Resources  PT Set at $53.00 by Seaport Global Securities
Targa Resources PT Set at $53.00 by Seaport Global Securities
Cognex  Raised to Buy at Zacks Investment Research
Cognex Raised to Buy at Zacks Investment Research
Gold Corporation Barrick Buys 1,293,324 Shares of Royal Road Minerals  Stock
Gold Corporation Barrick Buys 1,293,324 Shares of Royal Road Minerals Stock


© 2006-2018 Ticker Report. Google+.